Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Václavů, L, Meynart, BN, Mutsaerts, HJ, Petersen, ET, Majoie, CB, VanBavel, ET, Wood, JC, Nederveen, AJ & Biemond, BJ 2019, 'Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease' Haematologica, bind 104, nr. 4, s. 690-699. https://doi.org/10.3324/haematol.2018.206094

APA

Václavů, L., Meynart, B. N., Mutsaerts, H. J., Petersen, E. T., Majoie, C. B., VanBavel, E. T., ... Biemond, B. J. (2019). Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease. Haematologica, 104(4), 690-699. https://doi.org/10.3324/haematol.2018.206094

CBE

Václavů L, Meynart BN, Mutsaerts HJ, Petersen ET, Majoie CB, VanBavel ET, Wood JC, Nederveen AJ, Biemond BJ. 2019. Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease. Haematologica. 104(4):690-699. https://doi.org/10.3324/haematol.2018.206094

MLA

Vancouver

Author

Václavů, Lena ; Meynart, Benoit N ; Mutsaerts, Henk Jmm ; Petersen, Esben Thade ; Majoie, Charles Blm ; VanBavel, Ed T ; Wood, John C ; Nederveen, Aart J ; Biemond, Bart J. / Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease. I: Haematologica. 2019 ; Bind 104, Nr. 4. s. 690-699.

Bibtex

@article{1cf299cba84e4396bbe879399d0de432,
title = "Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease",
abstract = "Sickle cell disease is characterized by chronic hemolytic anemia and vascular inflammation, which can diminish the vasodilatory capacity of the small resistance arteries, making them less adept at regulating cerebral blood flow. Autoregulation maintains adequate oxygen delivery, but when vasodilation is maximized, the low arterial oxygen content can lead to ischemia and silent cerebral infarcts. We used magnetic resonance imaging of cerebral blood flow to quantify whole-brain cerebrovascular reserve in 36 adult patients with sickle cell disease (mean age, 31.9 ± 11.3 years) and 11 healthy controls (mean age, 37.4 ± 15.4 years), and we used high-resolution 3D FLAIR magnetic resonance imaging to determine the prevalence of silent cerebral infarcts. Cerebrovascular reserve was calculated as the percentage change in cerebral blood flow after a hemodynamic challenge with acetazolamide. Co-registered lesion maps were used to demonstrate prevalent locations for silent cerebral infarcts. Cerebral blood flow was elevated in patients with sickle cell disease compared to controls (median [interquartile range]: 82.8 [20.1] vs 51.3 [4.8] mL/100g/min, P <0.001). Cerebral blood flow was inversely associated with age, hemoglobin, and fetal hemoglobin, and correlated positively with bilirubin, and LDH, indicating that cerebral blood flow may reflect surrogates of hemolytic rate. Cerebrovascular reserve in sickle cell disease was decreased by half compared to controls (34.1 [33.4] vs 69.5 [32.4] {\%}, P <0.001) and was associated with hemoglobin and erythrocyte count indicating anemia-induced hemodynamic adaptations. 29/36 patients (81{\%}) and 5/11 controls (45{\%}) had silent cerebral infarcts (median volume of 0.34 vs 0.02 mL, P=0.03). Lesions were preferentially located in the borderzone. In conclusion, patients with sickle cell disease have a globally reduced cerebrovascular reserve as determined by arterial spin labeling with acetazolamide and reflects anemia-induced impaired vascular function in sickle cell disease. This study was registered at clinicaltrials.gov: NCT02824406.",
author = "Lena V{\'a}clavů and Meynart, {Benoit N} and Mutsaerts, {Henk Jmm} and Petersen, {Esben Thade} and Majoie, {Charles Blm} and VanBavel, {Ed T} and Wood, {John C} and Nederveen, {Aart J} and Biemond, {Bart J}",
note = "Copyright {\circledC} 2018, Ferrata Storti Foundation.",
year = "2019",
month = "4",
doi = "10.3324/haematol.2018.206094",
language = "English",
volume = "104",
pages = "690--699",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Fondazione/Ferrata Storti",
number = "4",

}

RIS

TY - JOUR

T1 - Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease

AU - Václavů, Lena

AU - Meynart, Benoit N

AU - Mutsaerts, Henk Jmm

AU - Petersen, Esben Thade

AU - Majoie, Charles Blm

AU - VanBavel, Ed T

AU - Wood, John C

AU - Nederveen, Aart J

AU - Biemond, Bart J

N1 - Copyright © 2018, Ferrata Storti Foundation.

PY - 2019/4

Y1 - 2019/4

N2 - Sickle cell disease is characterized by chronic hemolytic anemia and vascular inflammation, which can diminish the vasodilatory capacity of the small resistance arteries, making them less adept at regulating cerebral blood flow. Autoregulation maintains adequate oxygen delivery, but when vasodilation is maximized, the low arterial oxygen content can lead to ischemia and silent cerebral infarcts. We used magnetic resonance imaging of cerebral blood flow to quantify whole-brain cerebrovascular reserve in 36 adult patients with sickle cell disease (mean age, 31.9 ± 11.3 years) and 11 healthy controls (mean age, 37.4 ± 15.4 years), and we used high-resolution 3D FLAIR magnetic resonance imaging to determine the prevalence of silent cerebral infarcts. Cerebrovascular reserve was calculated as the percentage change in cerebral blood flow after a hemodynamic challenge with acetazolamide. Co-registered lesion maps were used to demonstrate prevalent locations for silent cerebral infarcts. Cerebral blood flow was elevated in patients with sickle cell disease compared to controls (median [interquartile range]: 82.8 [20.1] vs 51.3 [4.8] mL/100g/min, P <0.001). Cerebral blood flow was inversely associated with age, hemoglobin, and fetal hemoglobin, and correlated positively with bilirubin, and LDH, indicating that cerebral blood flow may reflect surrogates of hemolytic rate. Cerebrovascular reserve in sickle cell disease was decreased by half compared to controls (34.1 [33.4] vs 69.5 [32.4] %, P <0.001) and was associated with hemoglobin and erythrocyte count indicating anemia-induced hemodynamic adaptations. 29/36 patients (81%) and 5/11 controls (45%) had silent cerebral infarcts (median volume of 0.34 vs 0.02 mL, P=0.03). Lesions were preferentially located in the borderzone. In conclusion, patients with sickle cell disease have a globally reduced cerebrovascular reserve as determined by arterial spin labeling with acetazolamide and reflects anemia-induced impaired vascular function in sickle cell disease. This study was registered at clinicaltrials.gov: NCT02824406.

AB - Sickle cell disease is characterized by chronic hemolytic anemia and vascular inflammation, which can diminish the vasodilatory capacity of the small resistance arteries, making them less adept at regulating cerebral blood flow. Autoregulation maintains adequate oxygen delivery, but when vasodilation is maximized, the low arterial oxygen content can lead to ischemia and silent cerebral infarcts. We used magnetic resonance imaging of cerebral blood flow to quantify whole-brain cerebrovascular reserve in 36 adult patients with sickle cell disease (mean age, 31.9 ± 11.3 years) and 11 healthy controls (mean age, 37.4 ± 15.4 years), and we used high-resolution 3D FLAIR magnetic resonance imaging to determine the prevalence of silent cerebral infarcts. Cerebrovascular reserve was calculated as the percentage change in cerebral blood flow after a hemodynamic challenge with acetazolamide. Co-registered lesion maps were used to demonstrate prevalent locations for silent cerebral infarcts. Cerebral blood flow was elevated in patients with sickle cell disease compared to controls (median [interquartile range]: 82.8 [20.1] vs 51.3 [4.8] mL/100g/min, P <0.001). Cerebral blood flow was inversely associated with age, hemoglobin, and fetal hemoglobin, and correlated positively with bilirubin, and LDH, indicating that cerebral blood flow may reflect surrogates of hemolytic rate. Cerebrovascular reserve in sickle cell disease was decreased by half compared to controls (34.1 [33.4] vs 69.5 [32.4] %, P <0.001) and was associated with hemoglobin and erythrocyte count indicating anemia-induced hemodynamic adaptations. 29/36 patients (81%) and 5/11 controls (45%) had silent cerebral infarcts (median volume of 0.34 vs 0.02 mL, P=0.03). Lesions were preferentially located in the borderzone. In conclusion, patients with sickle cell disease have a globally reduced cerebrovascular reserve as determined by arterial spin labeling with acetazolamide and reflects anemia-induced impaired vascular function in sickle cell disease. This study was registered at clinicaltrials.gov: NCT02824406.

U2 - 10.3324/haematol.2018.206094

DO - 10.3324/haematol.2018.206094

M3 - Journal article

VL - 104

SP - 690

EP - 699

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -

ID: 55881306